Research programme: parasitic disease therapeutics and vaccines - Eisai/Oswaldo Cruz Foundation

Drug Profile

Research programme: parasitic disease therapeutics and vaccines - Eisai/Oswaldo Cruz Foundation

Alternative Names: E 6446; E6446 analogues - Eisai/Oswaldo Cruz Foundation (Fiocruz); Malaria therapeutics and vaccines - Eisai/Oswaldo Cruz Foundation (Fiocruz); Therapeutics and vaccines for neglected tropical diseases (NTDs) - Eisai/Oswaldo Cruz Foundation (Fiocruz)

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eisai Co Ltd; Oswaldo Cruz Foundation
  • Class Parasitic vaccines
  • Mechanism of Action Toll-like receptor 9 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Malaria; Parasitic infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Malaria in Brazil
  • 16 Jul 2016 No recent reports of development identified for research development in Malaria in Japan
  • 16 Jul 2016 No recent reports of development identified for research development in Parasitic-infections in Brazil
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top